IL-13 receptor-alpha2: a novel target for cancer therapy

Immunotherapy. 2009 May;1(3):321-7. doi: 10.2217/imt.09.8.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Antineoplastic Agents / immunology
  • Antineoplastic Agents / metabolism*
  • Clinical Trials as Topic
  • Cytokines / immunology
  • Cytokines / metabolism
  • Cytotoxicity, Immunologic
  • Humans
  • Immunotherapy*
  • Interleukin-13 Receptor alpha2 Subunit / genetics
  • Interleukin-13 Receptor alpha2 Subunit / immunology
  • Interleukin-13 Receptor alpha2 Subunit / metabolism*
  • Neoplasms / drug therapy*
  • Neoplasms / immunology*
  • STAT6 Transcription Factor / metabolism
  • Signal Transduction / drug effects
  • Signal Transduction / immunology
  • Th1-Th2 Balance / drug effects

Substances

  • Antineoplastic Agents
  • Cytokines
  • Interleukin-13 Receptor alpha2 Subunit
  • STAT6 Transcription Factor